Switch theme
Sign up to access all valuation multiples
Pulsenmore Ltd is engaged in developing portable ultrasound devices for home use. Its ultrasound scanner dock's with patients' smartphones to deliver images that can be created anywhere, stored and forwarded for clinical review, or shared in an online consultation.
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Pulsenmore has a last 12-month revenue of n/a and a last 12-month EBITDA of n/a.
In the most recent fiscal year, Pulsenmore achieved revenue of $2.6M and an EBITDA of -$9.1M.
Pulsenmore expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Pulsenmore valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $1.7M | $2.6M | XXX | XXX | XXX |
| Gross Profit | $1.4M | $0.6M | XXX | XXX | XXX |
| Gross Margin | 83% | 23% | XXX | XXX | XXX |
| EBITDA | -$15.0M | -$9.1M | XXX | XXX | XXX |
| EBITDA Margin | -896% | -346% | XXX | XXX | XXX |
| Net Profit | -$6.0M | -$15.9M | XXX | XXX | XXX |
| Net Margin | -357% | -606% | XXX | XXX | XXX |
| Net Debt | n/a | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, Pulsenmore's stock price is ILS 3 (or $1).
Pulsenmore has current market cap of ILS 163M (or $44.2M), and EV of ILS 61.2M (or $16.6M).
See Pulsenmore trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $16.6M | $44.2M | XXX | XXX | XXX | XXX | n/a |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, Pulsenmore has market cap of $44.2M and EV of $16.6M.
Pulsenmore's trades at n/a LTM EV/Revenue multiple, and n/a LTM EBITDA.
Analysts estimate Pulsenmore's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Pulsenmore and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $16.6M | XXX | XXX | XXX |
| EV/Revenue | 6.3x | XXX | XXX | XXX |
| EV/EBITDA | -1.8x | XXX | XXX | XXX |
| P/E | -4.4x | XXX | XXX | XXX |
| P/E/Growth | n/a | XXX | XXX | XXX |
| EV/FCF | -1.5x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpPulsenmore's NTM/LTM revenue growth is n/a
Pulsenmore's revenue per employee for the last fiscal year averaged n/a, while opex per employee averaged n/a for the same period.
Over next 12 months, Pulsenmore's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Pulsenmore's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Pulsenmore and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | 56% | XXX | XXX | XXX | XXX |
| EBITDA Margin | -346% | XXX | XXX | XXX | XXX |
| EBITDA Growth | -40% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | n/a | XXX | XXX | XXX | XXX |
| Revenue per Employee | n/a | XXX | XXX | XXX | XXX |
| Opex per Employee | n/a | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | 48% | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | 49% | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | 208% | XXX | XXX | XXX | XXX |
| Opex to Revenue | 474% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Philips | XXX | XXX | XXX | XXX | XXX | XXX |
| Perspective Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| SmartVest | XXX | XXX | XXX | XXX | XXX | XXX |
| InfuSystem | XXX | XXX | XXX | XXX | XXX | XXX |
| Myomo | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Pulsenmore acquired XXX companies to date.
Last acquisition by Pulsenmore was XXXXXXXX, XXXXX XXXXX XXXXXX . Pulsenmore acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| Where is Pulsenmore headquartered? | Pulsenmore is headquartered in Israel. |
| Is Pulsenmore publicy listed? | Yes, Pulsenmore is a public company listed on TAE. |
| What is the stock symbol of Pulsenmore? | Pulsenmore trades under PULS ticker. |
| When did Pulsenmore go public? | Pulsenmore went public in 2021. |
| Who are competitors of Pulsenmore? | Similar companies to Pulsenmore include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem. |
| What is the current market cap of Pulsenmore? | Pulsenmore's current market cap is $44.2M |
| What is the current revenue growth of Pulsenmore? | Pulsenmore revenue growth between 2023 and 2024 was 56%. |
| Is Pulsenmore profitable? | Yes, Pulsenmore is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
